Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Prepaid Assets (2020 - 2026)

Barinthus Biotherapeutics (BRNS) has disclosed Prepaid Assets for 7 consecutive years, with $4.2 million as the latest value for Q1 2026.

  • For Q1 2026, Prepaid Assets fell 32.71% year-over-year to $4.2 million; the TTM value through Mar 2026 reached $4.2 million, down 32.71%, while the annual FY2025 figure was $115000.0, 66.57% down from the prior year.
  • Prepaid Assets hit $4.2 million in Q1 2026 for Barinthus Biotherapeutics, up from $115000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $9.9 million in Q2 2022 and bottomed at $115000.0 in Q4 2025.
  • Average Prepaid Assets over 5 years is $4.4 million, with a median of $5.5 million recorded in 2022.
  • Year-over-year, Prepaid Assets skyrocketed 1539.42% in 2022 and then tumbled 96.53% in 2024.
  • Barinthus Biotherapeutics' Prepaid Assets stood at $8.3 million in 2022, then increased by 19.82% to $9.9 million in 2023, then crashed by 96.53% to $344000.0 in 2024, then plummeted by 66.57% to $115000.0 in 2025, then surged by 3589.57% to $4.2 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $4.2 million, $115000.0, and $6.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.